Physician profile
Drew Jackson Thomas
NPI 1235626334
$3,226.05
in general payments reported to CMS, 2019-2025
24 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $749 · 2023: $652 · 2024: $613 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863 · Education: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.66 |
| Education | $463.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $504.70 | 2021-2025 | Ensite, Ensite Precision, Cardiomems |
| Medtronic, INC. | $461.17 | 2024-2025 | Resolute Onyx, Onyx Frontier, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $284.14 | 2022-2025 | Avvigo Guidance System, Rotapro |
| Janssen Pharmaceuticals, INC | $233.93 | 2021-2022 | |
| Philips North America LLC | $226.83 | 2024-2025 | (Bh4) Igt Devices Undivided, Eagle Eye |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.08 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $199.29 | 2022-2024 | Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.36 | 2021-2024 | Jardiance |
| Abiomed | $134.37 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $130.18 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $124.88 | 2023 | Xarelto |
| Pfizer INC. | $117.08 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $109.31 | 2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $73.20 | 2024 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $55.40 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $33.13 | 2021-2022 | |
| Angiodynamics, INC. | $32.86 | 2025 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $25.00 | 2025 | Penumbra System |
| Cardiva Medical, INC. | $24.06 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Siemens Medical Solutions USA, INC. | $18.36 | 2024 | |
| Teleflex LLC | $15.88 | 2023 | Manta |
| Actelion Pharmaceuticals US, INC. | $15.08 | 2021 | |
| Esperion Therapeutics, INC. | $15.04 | 2021 | |
| Amgen INC. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.